191 related articles for article (PubMed ID: 22624040)
21. K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis.
Zhao J; Punj V; Matta H; Mazzacurati L; Schamus S; Yang Y; Yang T; Hong Y; Chaudhary PM
PLoS One; 2007 Oct; 2(10):e1067. PubMed ID: 17957251
[TBL] [Abstract][Full Text] [Related]
22. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
23. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases.
Pan ZG; Zhang QY; Lu ZB; Quinto T; Rozenvald IB; Liu LT; Wilson D; Reddy V; Huang Q; Wang HY; Ren YS
Am J Surg Pathol; 2012 Aug; 36(8):1129-40. PubMed ID: 22790853
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
Zhang YJ; Patel D; Nan Y; Fan S
Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
[TBL] [Abstract][Full Text] [Related]
25. Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells.
Punj V; Matta H; Schamus S; Chaudhary PM
BMC Med Genomics; 2009 Aug; 2():50. PubMed ID: 19660139
[TBL] [Abstract][Full Text] [Related]
26. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.
Carbone A; Cesarman E; Gloghini A; Drexler HG
AIDS; 2010 Feb; 24(4):479-90. PubMed ID: 20051807
[TBL] [Abstract][Full Text] [Related]
27. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
[TBL] [Abstract][Full Text] [Related]
28. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
29. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways.
An J; Sun Y; Sun R; Rettig MB
Oncogene; 2003 May; 22(22):3371-85. PubMed ID: 12776188
[TBL] [Abstract][Full Text] [Related]
31. Generation of a KSHV K13 deletion mutant for vFLIP function study.
Wang F; Guo Y; Li W; Lu C; Yan Q
J Med Virol; 2018 Apr; 90(4):753-760. PubMed ID: 29244209
[TBL] [Abstract][Full Text] [Related]
32. Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.
Poole LJ; Yu Y; Kim PS; Zheng QZ; Pevsner J; Hayward GS
J Virol; 2002 Apr; 76(7):3395-420. PubMed ID: 11884566
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation.
Matta H; Mazzacurati L; Schamus S; Yang T; Sun Q; Chaudhary PM
J Biol Chem; 2007 Aug; 282(34):24858-65. PubMed ID: 17597077
[TBL] [Abstract][Full Text] [Related]
34. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Virus-Associated Lymphoma Growth and Gene Expression by Bacterial Quorum-Sensing Molecules.
Qiao J; Cao Y; Zabaleta J; Yang L; Dai L; Qin Z
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743366
[TBL] [Abstract][Full Text] [Related]
36. An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis.
Zhu Y; Ramos da Silva S; He M; Liang Q; Lu C; Feng P; Jung JU; Gao SJ
PLoS Pathog; 2016 May; 12(5):e1005648. PubMed ID: 27187079
[TBL] [Abstract][Full Text] [Related]
37. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
[TBL] [Abstract][Full Text] [Related]
38. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
39. Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-κB pathway.
Matsuno T; Kariya R; Yano S; Morino-Koga S; Taura M; Suico MA; Shimauchi Y; Matsuyama S; Okamoto Y; Shuto T; Kai H; Okada S
Int J Oncol; 2012 Apr; 40(4):1071-8. PubMed ID: 22200846
[TBL] [Abstract][Full Text] [Related]
40. Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma.
Dai L; Cao Y; Chen Y; Kaleeba JA; Zabaleta J; Qin Z
Oncotarget; 2015 May; 6(14):12710-22. PubMed ID: 25860939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
